{
    "title": "Genmab and J&J's cancer drug set for blockbuster sales this year",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4249900/Genmab-J-Js-cancer-drug-set-blockbuster-sales-year.html",
    "date": "2017-02-22",
    "keywords": [
        "darzalex",
        "year",
        "biotech",
        "genmab",
        "company",
        "revenue",
        "drug",
        "johnson",
        "jampj",
        "range",
        "copenhagen",
        "drugmaker",
        "cancer",
        "bone",
        "marrow",
        "wednesdayin",
        "firm",
        "operating",
        "profit",
        "guidance",
        "back",
        "performance",
        "myeloma",
        "blockbuster",
        "drugsnet",
        "amp",
        "thomson",
        "percent",
        "business",
        "marketgenmab",
        "milestone",
        "income",
        "market",
        "capitalisation",
        "actelion",
        "amgen",
        "celgenegenmabs",
        "chief",
        "executive",
        "jan",
        "winkel",
        "wider",
        "cancers1",
        "crownsreporting",
        "jacobsen",
        "editing",
        "hardcastle"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}